Gastric Cancer
Copyright ©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Feb 7, 2005; 11(5): 623-628
Published online Feb 7, 2005. doi: 10.3748/wjg.v11.i5.623
Table 3 Expression of ERK-1, ERK-2, ERK-3, p38 and MEK-1 in metastatic lymph nodes (mean±SD).
ItemsnIOD valuetP
ERK-1
Metastatic lymph nodes14195734.7±70508.8
Primary site210423.7±74207.30.6080.554b
Normal mucosa155862.3±79052.81.4530.170a
ERK-2
Metastatic lymph nodes14186959.5±80801.8
Primary site211155.1±64116.80.8930.388b
Normal mucosa127092.4±56585.62.5790.023a
ERK-3
Metastatic lymph nodes14140323.2±120532.0
Primary site98732.1±54021.31.2610.230b
Normal mucosa50032.9±58937.83.116<0.001a
P38
Metastatic lymph nodes1296866.8±76857.3
Primary site99740.6±38279.60.2020.844b
Normal mucosa77784.4±30367.00.7970.442a
MEK-1
Metastatic lymph nodes12133353.9±42374.3
Primary site101112.5±39124.02.2030.05b
Normal mucosa77431.9±31282.14.235<0.001a